Erin Weslander
YOU?
Author Swipe
View article: P-1740. Impact of a System Wide Antimicrobial Stewardship Intervention Bundle to Improve Guideline Directed Antibiotics for Urinary Tract Infections
P-1740. Impact of a System Wide Antimicrobial Stewardship Intervention Bundle to Improve Guideline Directed Antibiotics for Urinary Tract Infections Open
Background Urinary tract infections (UTIs) are one of the common reasons for antibiotic use across healthcare settings. Across an eleven-hospital system, common urinary pathogens (E. coli, Proteus species, and Klebsiella species) had great…
View article: P-372. <i>Candida auris</i> Outbreak in a Cardiothoracic Transplant Intensive Care Unit: Implications for Infection Prevention
P-372. <i>Candida auris</i> Outbreak in a Cardiothoracic Transplant Intensive Care Unit: Implications for Infection Prevention Open
Background Candida auris is a yeast that causes invasive infections such as bloodstream infections (BSIs); mortality rates for C. auris BSIs may be as high as 80%. Rates have been climbing in the U.S. Exposure to skilled nursing facilities…
View article: P-1727. Impact of Four-Day Automatic-Stop Orders on the Duration of Antibiotic Treatment
P-1727. Impact of Four-Day Automatic-Stop Orders on the Duration of Antibiotic Treatment Open
Background Implementation of automatic antibiotic stop orders is an antimicrobial stewardship intervention that encourages timely antibiotic order re-evaluation for potential discontinuation, spectrum de-escalation, transition to oral ther…
View article: P-1634. Prescribing Patterns of Antibiotics in an Academic Medical Center Internal Medicine Clinic
P-1634. Prescribing Patterns of Antibiotics in an Academic Medical Center Internal Medicine Clinic Open
Background Antimicrobial stewardship is critical in the prevention of antibiotic resistance. The CDC estimates nearly 90% of antibiotic use occurs in outpatient settings, with up to half of the prescriptions not carrying appropriate indica…
View article: P-1253. Validating and Comparing the Predictiveness of Cefepime Pharmacokinetic Models Used in Bayesian Dosing
P-1253. Validating and Comparing the Predictiveness of Cefepime Pharmacokinetic Models Used in Bayesian Dosing Open
Background Bayesian software may enhance beta-lactam dosing. Therefore, we analyzed the predictiveness of cefepime pharmacokinetic (PK) models for use as Bayesian priors. Methods Data on adult patients receiving cefepime intravenous therap…
View article: 210. Implementation of a Pharmacist Driven Beta-lactam Therapeutic Drug Monitoring Program with Daily Result Reporting: Initial Experiences and Challenges Faced
210. Implementation of a Pharmacist Driven Beta-lactam Therapeutic Drug Monitoring Program with Daily Result Reporting: Initial Experiences and Challenges Faced Open
Background Beta-lactam (BL) antibiotics are a cornerstone of treatment for patients with serious infections. Individualized BL dosing using therapeutic drug monitoring (TDM) is an emerging approach to address variability in BL exposure tha…
View article: 211. Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice
211. Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice Open
Background Clinicians performing beta-lactam therapeutic drug monitoring (TDM) lack evidence on when levels should ideally be drawn after a dose. Herein, we define the optimal timing (i.e., optimal sampling) for cefepime using real-world T…
View article: P-1745. Development and Use of a System Antimicrobial Stewardship Dashboard
P-1745. Development and Use of a System Antimicrobial Stewardship Dashboard Open
Background Obtaining data has been an ongoing challenge for antimicrobial stewardship programs. With the creation and recent update of the Joint Commission antimicrobial stewardship standards, an increased focus has been placed on acting o…
View article: 1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prevalence study aimed to prioritize non-invasive delabeling for antimicrobial stewardship programs
1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prevalence study aimed to prioritize non-invasive delabeling for antimicrobial stewardship programs Open
Background This study aimed to use data analytics to retrospectively identify the prevalence of inpatients across a system of hospitals with a BAAL who received and tolerated the culprit or related beta-lactam (BL) without proper documenta…
View article: 1275. Impact of a bundled antimicrobial stewardship intervention leveraging frontline pharmacist response to rapid blood culture diagnostics at an academic medical center and community hospital
1275. Impact of a bundled antimicrobial stewardship intervention leveraging frontline pharmacist response to rapid blood culture diagnostics at an academic medical center and community hospital Open
Background Rapid Blood Culture Identification (BCID) panels have been shown to improve patient outcomes, including mortality and length of stay, when paired with antimicrobial stewardship (ASP) intervention. We report the results of a qual…
View article: 1230. Optimization of a Public-Facing Health System Antimicrobial Stewardship Website
1230. Optimization of a Public-Facing Health System Antimicrobial Stewardship Website Open
Background Following health system integration of an academic medical center and 10 community hospitals, efforts were made to unify the individual antimicrobial stewardship programs (ASP) and standardize resources within a system-wide Anti…
View article: 1221. Non-severe, non-immune mediated intolerances: simple targets for direct non-invasive delabeling opportunities of beta-lactam antibiotic allergy labels (BAAL)
1221. Non-severe, non-immune mediated intolerances: simple targets for direct non-invasive delabeling opportunities of beta-lactam antibiotic allergy labels (BAAL) Open
Background Majority of patients with a BAALs can tolerate a β-lactam without concerns for a severe IgE-mediated reaction. Many BAALs are confirmed to be intolerances or adverse events versus a true allergy. False BAALs can result in the us…
View article: 1322. Infectious Complications Following Pediatric Lawn Mower Injury: A Case Series
1322. Infectious Complications Following Pediatric Lawn Mower Injury: A Case Series Open
Background According to the National Electronic Injury Surveillance System, there are an estimated 9,400 riding lawn mower injuries in the United States in pediatric patients per year. Previous case series report a 7-12.5% infection rate a…